Abstract IA05: Prospective identification of vulnerabilities to DNA repair inhibitors

The advent of CRISPR/Cas9 as a gene editing tool has enable the development of genome-scale libraries of single-guide RNAs that can be used to probe biological processes. CRISPR/Cas9 screens can be used to profile the essential gene complement of cancer cell lines, map genetic interactions and chart the response to drugs. During my presentation, I will present our efforts to map the genetic networks that govern the DNA damage response and will discuss our work aimed at mapping the genetic architecture of the response to PARP inhibitors. Our work revealed new types of genetic vulnerabilities to PARP inhibition and in particular, I will discuss a type DNA lesion that could act as the elusive inhibited-PARP "trap".Citation Format: Daniel Durocher. Prospective identification of vulnerabilities to DNA repair inhibitors [abstract]. In: Proceedings of the AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response; 2016 Nov 2-5; Montreal, QC, Canada. Philadelphia (PA): AACR; Mol Cancer Res 2017;15(4_Suppl):Abstract nr IA05.
Source: Molecular Cancer Research - Category: Cancer & Oncology Authors: Tags: Homologous Recombination Defects: Oral Presentations - Invited Abstracts Source Type: research